{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:18Z","timestamp":1787026998921,"version":"build-2736575974"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>This study reports a case of a 47-year-old female who was initially misdiagnosed as having liver abscess due to repeated fever, and was later misdiagnosed again as liver inflammatory myofibroblastic tumor(IMT) after liver biopsy. After surgical removal, molecular pathological examination confirmed the diagnosis of Hepatic epithelioid hemangioendothelioma(HEHE). HEHE with fever as the main symptom is extremely rare and there are no similar reports available at present. This study summarizes the key points of HEHE diagnosis and treatment, analyzes the reasons for the misdiagnosis in this case and the possible factors causing the fever symptoms, highlights the difficulties in HEHE diagnosis and the significant value of molecular pathology in its diagnosis.<\/jats:p>","DOI":"10.3389\/fonc.2025.1606872","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T13:04:02Z","timestamp":1756731842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report of misdiagnosis: a rare case of hepatic epithelioid hemangioendothelioma characterized primarily by fever"],"prefix":"10.3389","volume":"15","author":[{"given":"Jian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-22-80","article-title":"Hepatic epithelioid hemangioendothelioma: pitfalls in the treatment of a rare liver Malignancy","volume":"8","author":"Dogeas","year":"2023","journal-title":"Transl Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2024.42.16_suppl.e23525","article-title":"Epithelioid hemangioendothelioma: Real-world data about a rare entity in a Portuguese tertiary cancer center","volume":"42","author":"Cabral","year":"2024","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.hbpd.2019.11.006","article-title":"Treatment and\u00a0prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014","volume":"19","author":"Noh","year":"2019","journal-title":"Hepatob Pancreat Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i17.5606","article-title":"Hepatic epithelioid hemangioendothelioma: Clinical characteristics, diagnosis, treatment, and prognosis","volume":"10","author":"Zhao","year":"2022","journal-title":"World J Clin Cases"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2020.100568","article-title":"VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature","volume":"44","author":"Telli","year":"2020","journal-title":"Curr PROB CANCER"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.10.010","article-title":"Hepatic epithelioid hemangioendothelioma: an unusual lesion of the liver","volume":"10","author":"Lupinacci","year":"2011","journal-title":"Clin Gastroenterol H"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1820-9","article-title":"The \u201cTarget sign\u201d and the \u201cLollipop sign\u201d in hepatic epithelioid hemangioendothelioma","volume":"44","author":"Mamone","year":"2019","journal-title":"ABDOM Radiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-022-01344-y","article-title":"CT and MRI features of hepatic epithelioid haemangioendothelioma: a multi-institutional retrospective analysis of 15 cases and a literature review","volume":"14","author":"Luo","year":"2023","journal-title":"Insights Imaging"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2016.0105","article-title":"Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review","volume":"14","author":"Afrit","year":"2017","journal-title":"Cancer Biol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e15496","DOI":"10.1111\/1759-7714.15496","article-title":"Clinicopathological characteristics of inflammatory myofibroblastic tumor: A single center retrospective cohort study","volume":"16","author":"Si","year":"2023","journal-title":"Thorac Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2024.42.16_suppl.10046","article-title":"Targeted treatment in inflammatory myofibroblastic tumors in children","volume":"42","author":"Kebudi","year":"2023","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1401428","article-title":"A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement","volume":"15","author":"Zheng","year":"2023","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2021.39.15_suppl.e23554","article-title":"Loss of 5\u2019ALK leads to better response to crizotinib in sarcomas with ALK rearrangement","volume":"39","author":"Li","year":"2021","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","article-title":"A pan-cancer analysis of the microbiome in metastatic cancer","volume":"187","author":"Battaglia","year":"2024","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221086909","article-title":"Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation","volume":"14","author":"Kounis","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.4_suppl.186","article-title":"Does a common vascular origin confer similar prognosis to Malignant tumors of the liver","volume":"30","author":"Groeschl","year":"2012","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1606872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T13:04:03Z","timestamp":1756731843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1606872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":16,"alternative-id":["10.3389\/fonc.2025.1606872"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1606872","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1606872"}}